The relationship between physician and cancer patient when initiating adjuvant treatment and its association with sociodemographic and clinical variables

dc.contributor.authorJiménez Fonseca, Paula
dc.contributor.authorCalderón Garrido, Caterina
dc.contributor.authorCarmona Bayonas, Alberto
dc.contributor.authorMuñoz, Maria del Mar
dc.contributor.authorHernández San Gil, Raquel
dc.contributor.authorMut-Lloret, Margarida
dc.contributor.authorGhanem, Ismael
dc.contributor.authorBeato, Carmen
dc.contributor.authorCacho Lavín, Diego
dc.contributor.authorIvars Rubio, A.
dc.contributor.authorCarrión Galindo, Rafael
dc.contributor.authorJara, Carlos
dc.date.accessioned2020-03-31T14:16:53Z
dc.date.available2020-03-31T14:16:53Z
dc.date.issued2018-05-05
dc.date.updated2020-03-31T14:16:53Z
dc.description.abstractPurpose The aim of this study was to analyze differences in physician and patient satisfaction in shared decision-making (SDM); patients' emotional distress, and coping in subjects with resected, non-metastatic cancer. Methods 602 patients from 14 hospitals in Spain were surveyed. Information was collected regarding physician and patient satisfaction with SDM, participants' emotional distress and coping, as well as patient sociodemographic and clinical characteristics by means of specific, validated questionnaires. Results Overall, 11% of physicians and 19% of patients were dissatisfied with SDM; 22% of patients presented hopelessness or anxious preoccupation as coping strategies, and 56% presented emotional distress. By gender, female patients showed a higher prevalence of dissatisfaction with SDM (23 vs 14%), anxious preoccupation (26 vs 17%), and emotional distress (63 vs 44%) than males. Hopelessness was more prevalent in individuals with stage III disease than those with stages I-II (28 vs 18%). Conclusion Physicians must be mindful of the importance of emotional support and individual characteristics when communicating treatment options, benefits, and adverse effects of each alternative to oncological patients.
dc.format.extent8 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec680398
dc.identifier.issn1699-048X
dc.identifier.urihttps://hdl.handle.net/2445/154549
dc.language.isoeng
dc.publisherSpringer Verlag
dc.relation.isformatofVersió postprint del document publicat a: https://doi.org/10.1007/s12094-018-1870-z
dc.relation.ispartofClinical & Translational Oncology, 2018, vol. 20, num. 11, p. 1392-1399
dc.relation.urihttps://doi.org/10.1007/s12094-018-1870-z
dc.rights(c) Federación de Sociedades Españolas de Oncología (FESEO), 2018
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.sourceArticles publicats en revistes (Psicologia Clínica i Psicobiologia)
dc.subject.classificationCàncer
dc.subject.classificationQuimioteràpia del càncer
dc.subject.classificationRelacions metge-pacient
dc.subject.otherCancer
dc.subject.otherCancer chemotherapy
dc.subject.otherPhysician-patient relationships
dc.titleThe relationship between physician and cancer patient when initiating adjuvant treatment and its association with sociodemographic and clinical variables
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/acceptedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
680398.pdf
Mida:
917.86 KB
Format:
Adobe Portable Document Format